Filtering

P686: Application of dried blood spots for pharmacokinetic profiling of golimumab-treated patients with ulcerative colitisECCO '17 Barcelona
Year: 2017
Authors:

Detrez I.*1, Ballet V.2, Van Assche G.2, Vermeire S.2, Ferrante M.2, Gils A.1

1KU Leuven, Department of Pharmaceutical and Pharmacological Sciences, Leuven, Belgium 2UZ Leuven, Department of Clinical and Experimental Medicine, Leuven, Belgium

P687: Fate of the rectum in anorectal Crohn's diseaseECCO '17 Barcelona
Year: 2017
Authors:

Zambonin D., Scaringi S., Di Bella A., Giudici F., Bechi P.

University of Florence, Florence, Italy

P688: Crohn's disease patients with a concordant family history are diagnosed earlier and are at increased risk for complicated diseaseECCO '17 Barcelona
Year: 2017
Authors:

Borren N.*1,2, Conway G.1, Garber J.1,3, Khalili H.1,3, Yajnik V.1,3, Xavier R.1,3, Ananthakrishnan A.1,3

1Massachusetts General Hospital, Department of Gastroenterology, Boston, United States 2University of Groningen, Groningen, Netherlands 3Harvard Medical School, Boston, United States

P689: Biologics utilization in children with inflammatory bowel diseases is higher and earlier than in adults: a report from the epi-IIRN groupECCO '17 Barcelona
Year: 2017
Authors:

Friedman M.*1, Axelrod R.1,2, Rosenblum J.3, Zigman N.3, Goren I.3, Lederman N.4, Cohen N.4, Matz E.5, Dushnitzky D.5, Borovsky N.5, Gavish M.2, Focht G.1, Avitzour M.1, Dotan I.6, Benchimol E.7, Turner D.1

1Shaare Zedek Medical Center, The Juliet Keiden Institute of Pediatric Gastroenterology and Nutrition, Jerusalem, Israel 2The Hebrew University of Jerusalem, School of Computer Science and Engineering, Jerusalem, Israel 3Maccabi Healthcare Services, Tel Aviv, Israel 4Meuhedet Health Services, Tel Aviv, Israel 5Leumit Health Services, Tel Aviv, Israel 6Tel-Aviv Sourasky Medical Center, and the Sackler School of Medicine, IBD Center, Department of Gastroenterology and Liver diseases, Tel Aviv, Israel 7Children's Hospital of Eastern Ontario, University of Ottawa, CHEO Inflammatory Bowel Disease Centre, Ottawa, Canada

P690: Ambient air quality does not affect disease course in inflammatory bowel disease – a population based risk factor analysis using geographic information systemsECCO '17 Barcelona
Year: 2017
Authors:

van den Heuvel T.*1, Bijnens E.2, Verhaegh B.1,3, Nawrot T.2, Zeegers M.4,5, Masclee A.1,3, Oostenbrug L.6, Romberg-Camps M.6, Jonkers D.1, Pierik M.1

1Maastricht University Medical Centre+, Division of Gastroenterology and Hepatology, Maastricht, Netherlands 2Hasselt University, Centre for Environmental Sciences, Diepenbeek, Belgium 3Maastricht University Medical Centre+, Nutrim - School of Nutrition and Translational Research in Metabolism, Maastricht, Netherlands 4Maastricht University Medical Centre+, Department of Complex Genetics, Maastricht, Netherlands 5Maastricht University Medical Centre+, Caphri - School of Public Health and Primary Care, Maastricht, Netherlands 6Zuyderland Medical Centre, Department of Internal Medicine, Sittard-Geleen-Heerlen, Netherlands

P691: UV exposure and skin type are more important than thiopurine exposure for non-melanoma skin cancer risk in IBDECCO '17 Barcelona
Year: 2017
Authors:

Wu Y.*1, Ghaly S.1, Kerr S.2, Krishnaprasad K.3, Prosser R.4, Jackson B.5, Hanigan K.3, Martins D.3, Mountifield R.4, Whiteman D.6, Bampton P.4, Gearry R.5, Radford-Smith G.3, Lawrance I.C.7,8

1St Vincent's Hospital, Department of Gastroenterology, Sydney, Australia 2Kirby Institute, Sydney, Australia 3QIMR Berghofer Medical Research Insitute, Inflammatory Bowel Disease Research Group, Brisbane, Australia 4Flinders Medical Centre, Department of Gastroenterology, Adelaide, Australia 5Christchurch Hospital, Department of Gastroenteology, Christchurch, New Zealand 6QIMR Berghofer Medical Research Insitute, Cancer Control Group, Brisbane, Australia 7University of Western Australia, School of Medicine and Pharmacology, Perth, Australia 8St John of God Hospital, Centre for inflammatory Bowel Diseases, Perth, Australia

P692: Inflammatory bowel diseases in Faroese-born Danish residents and their offspring. Further evidence of the dominant role of environmental factors in IBD developmentECCO '17 Barcelona
Year: 2017
Authors:

Hammer T.*1,2, Lophaven S.N.1, Rubek Nielsen K.3,4, von Euler-Chelpin M.C.1, Weihe P.2, Munkholm P.5, Burisch J.5, Lynge E.1

1University of Copenhagen, Department of Public Health, Copenhagen, Denmark 2The Department of Occupational Medicine and Public Health, Tόrshavn, Faroe Islands 3Medical Centre, National Hospital of the Faroe Islands, Tόrshavn, Faroe Islands 4Genetic Biobank, Tόrshavn, Faroe Islands 5Department of Gastroenterology, North Zealand Hospital, Copenhagen, Denmark

P693: Patients with inflammatory bowel disease who are on immunosuppressive therapy perform regular gynecologic screening for uterine cervical cancer?ECCO '17 Barcelona
Year: 2017
Authors:

Vázquez-Morόn J.M., Cabello Fernández A., Pallarés-Manrique H., Ramos-Lora M.

Hospital General Juan Ramόn Jiménez, Gastroenterology Unit, Huelva, Spain

P694: Disease course during the first five years following diagnosis in a prospective European population-based inception cohort – the ECCO-EpiCom cohortECCO '17 Barcelona
Year: 2017
Authors:

Burisch J.*1, Halfvarson J.2, Kupcinskas L.3, Hernandez V.4, Kaimakliotis I.5, Valpiani D.6, Pedersen N.7, Duricova D.8, Kievit L.9, Dahlerup J.F.10, Fumery M.11, Salupere R.12, Arebi N.13, Nielsen K.R.14, Giannotta M.15, Oksanen P.16, Katsanos K.H.17, Vegh Z.18, Ellul P.19, Schwartz D.20, Čuković-Čavka S.21, D'Incà R.22, Turcan S.23, Magro F.24,25,26, Goldis A.27, Langholz E.28, Lakatos P.L.18, Munkholm P.1 EpiCom Study Group

1North Zealand University Hospital, Department of Gastroenterology, Frederikssund, Denmark 2Faculty of Medicine and Health, Örebro University, Department of Gastronterology, Örebro, Sweden 3Lithuanian University of Health Sciences, Institute for Digestive Research, Kaunas, Lithuania 4Complexo Hospitalario Universitario de Vigo, Gastroenterology Department, Vigo, Spain 5Nicosia Private practice, Nicosia Private Practice, Nicosia, Cyprus 6Department of Gastroenterology and Digestive Endoscopy, Morgagni Hospital, Forli, Italy 7Slagelse Hospital, Department of Gastroenterology, Slagelse, Denmark 8Charles University, IBD Center ISCARE, Prague, Czech Republic 9Herning Central Hospital, Department of Medicine, Herning, Denmark 10Aarhus University Hospital, Department of Hepatology and Gastroenterology, Aarhus, Denmark 11Amiens University and Hospital, Epimad Registry, Gastroenterology Unit, Amiens, France 12Tartu University Hospital, Division of Endocrinology and Gastroenterology, Tartu, Estonia 13St Mark's Hospital, Gastroenterology, London, United Kingdom 14The National Hospital of the Faroe Islands, Medical Department, Tόrshavn, Faroe Islands 15AOU Careggi Regional Referral Center for Inflammatory Bowel Disease, Gastroenterology Department, Florence, Italy 16Tampere University Hospital, Department of Gastroenterology and Alimentary Tract Surgery, Tampere, Finland 17University Hospital, Ioannina, 1st Division of Internal Medicine and Hepato-Gastroenterology Unit, Ioannina, Greece 18Semmelweis University, 1st Department of Medicine, Budapest, Hungary 19Mater Dei Hospital, Division of Gastroenterology, L-Imsida, Malta 20Soroka Medical Center and Ben Gurion University of the Negev, Department of Gastroenterology and Hepatology, Beer Sheva, Israel 21University Hospital Center Zagreb, University of Zagreb School of Medicine, Division of Gastroenterology and Hepatology, Zagreb, Croatia 22Azienda Ospedaliera di Padova, Department of Surgery, Oncology and Gastroenterology, Padova, Italy 23State University of Medicine and Pharmacy of the Republic of Moldova, Department of Gastroenterology, Chisinau, Moldova, Republic of 24University of Porto, Institute for Molecular and Cell Biology, Porto, Portugal 25Hospital de São João, Department of Gastroenterology, Porto, Portugal 26Oporto Medical School, Institute of Pharmacology and Therapeutics, Porto, Portugal 27University of Medicine “Victor Babes”, Clinic of Gastroenterology, Timisoara, Romania 28Gentofte Hospital, Department of Medical Gastroenterology, Copenhagen, Denmark

P695: The risk of proximal disease extension in patients with limited ulcerative colitis in a prospective European population-based inception cohort – the ECCO-EpiCom cohortECCO '17 Barcelona
Year: 2017
Authors:

Burisch J.*1, Halfvarson J.2, Kupcinskas L.3, Hernandez V.4, Kaimakliotis I.5, Valpiani D.6, Pedersen N.7, Duricova D.8, Kievit L.9, Dahlerup J.F.10, Fumery M.11, Salupere R.12, Arebi N.13, Nielsen K.R.14, Giannotta M.15, Oksanen P.16, Katsanos K.H.17, Vegh Z.18, Ellul P.19, Schwartz D.20, Čuković-Čavka S.21, D'Incà R.22, Turcan S.23, Magro F.24,25,26, Goldis A.27, Langholz E.28, Lakatos P.L.18, Munkholm P.1 EpiCom Study Group

1North Zealand University Hospital, Department of Gastroenterology, Frederikssund, Denmark 2Faculty of Medicine and Health, Örebro University, Department of Gastronterology, Örebro, Sweden 3Lithuanian University of Health Sciences, Institute for Digestive Research, Kaunas, Lithuania 4Complexo Hospitalario Universitario de Vigo, Gastroenterology Department, Vigo, Spain 5Nicosia Private practice, Nicosia Private practice, Nicosia, Cyprus 6Department of Gastroenterology and Digestive Endoscopy, Morgagni Hospital, Forli, Italy 7Slagelse Hospital, Department of Gastroenterology, Slagelse, Denmark 8Charles University, IBD Center ISCARE, Prague, Czech Republic 9Herning Central Hospital, Department of medicine, Herning, Denmark 10Aarhus University Hospital, Department of Hepatology and Gastroenterology, Aarhus, Denmark 11Amiens University and Hospital, Epimad Registry, Gastroenterology Unit, Amiens, France 12Tartu University Hospital, Division of Endocrinology and Gastroenterology, Tartu, Estonia 13St Mark's Hospital, Gastroenterology, London, United Kingdom 14The National Hospital of the Faroe Islands, Medical department, Tόrshavn, Faroe Islands 15AOU Careggi Regional Referral Center for Inflammatory Bowel Disease, Gastroenterology Department, Florence, Italy 16Tampere University Hospital, Department of Gastroenterology and Alimentary Tract Surgery, Tampere, Finland 17University Hospital, Ioannina, 1st Division of Internal Medicine and Hepato-Gastroenterology Unit, Ioannina, Greece 18Semmelweis University, 1st Department of Medicine, Budapest, Hungary 19Mater Dei Hospital, Division of Gastroenterology, L-Imsida, Malta 20Soroka Medical Center and Ben Gurion University of the Negev, Department of Gastroenterology and Hepatology, Beer Sheva, Israel 21University Hospital Center Zagreb, University of Zagreb School of Medicine, Division of Gastroenterology and Hepatology, Zagreb, Croatia 22Azienda Ospedaliera di Padova, Department of Surgery, Oncology and Gastroenterology, Padova, Italy 23State University of Medicine and Pharmacy of the Republic of Moldova, Department of Gastroenterology, Chisinau, Moldova, Republic of 24University of Porto, Institute for molecular and cell biology, Porto, Portugal 25Hospital de São João, Department of Gastroenterology, Porto, Portugal 26Oporto Medical School, Institute of Pharmacology and Therapeutics, Porto, Portugal 27University of Medicine “Victor Babes”, Clinic of Gastroenterology, Timisoara, Romania 28Gentofte Hospital, Department of Medical Gastroenterology, Copenhagen, Denmark

P696: Ambient air quality as risk factor for microscopic colitis – a Geographic Information System studyECCO '17 Barcelona
Year: 2017
Authors:

Verhaegh B.P.M.*1,2, Beijnens E.M.3, van den Heuvel T.R.A.1, Goudkade D.4, Zeegers M.P.2,5, Nawrot T.S.3, Masclee A.A.M.1,2, Jonkers D.M.A.E.1,2, Pierik M.J.1

1Maastricht University Medical Center+, Internal Medicine - Division of Gastroenterology-Hepatology, Maastricht, Netherlands 2Maastricht University Medical Center+, NUTRIM, School of Nutrition and Translational Research in Metabolism, Maastricht, Netherlands 3Hasselt University, Center for Environmental Sciences, Diepenbeek, Belgium 4Maastricht University Medical Center+, Pathology, Maastricht, Netherlands 5Maastricht University Medical Center+, Complex Genetics, Cluster of Genetics and Cell Biology, Maastricht, Netherlands

P697: Association of inflammatory bowel disease and celiac disease. Experience in a hospital of the autonomous community of Madrid (Spain)ECCO '17 Barcelona
Year: 2017
Authors:

Manceñido Marcos N.*1, Pajares Villarroya R.1, Salinas Moreno S.2, Arribas Lόpez M.R.1, Comas Redondo C.1

1Hospital Universitario Infanta Sofía, Gastroenterology Department, San Sebastián de los Reyes (Madrid), Spain 2Hospital Universitario Infanta Sofía, Pathology Department, San Sebastián de los Reyes (Madrid), Spain

P698: The risk of developing subsequent immune mediated inflammatory diseases: a retrospective matched cohort studyECCO '17 Barcelona
Year: 2017
Authors:

Panaccione R.*1, Aletaha D.2, Davis M.3, Johnson S.3, Skup M.4, Garg V.4

1University of Calgary, Calgary, Canada 2Medical University of Vienna, Vienna, Austria 3Medicus Economics, LLC, Milton, United States 4AbbVie Inc., North Chicago, United States

P699: Impact of adalimumab's patient support program on clinical outcomes in inflammatory bowel diseases: results from the COMPANION studyECCO '17 Barcelona
Year: 2017
Authors:

Marshall J.K.*1,2, Narula N.1, Lebovic G.3,4, Millson B.5, Charland K.5, Sung M.5, Gaetano T.6, McHugh K.6, Latour M.6, Laliberte M.-C.6

1McMaster University, Department of Gastroenterology, Hamilton, Canada 2Farncombe Family Digestive Health Research Institute, Hamilton, Canada 3Applied Health Research Centre, St. Michael's Hospital, Toronto, Canada 4Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada 5QuintilesIMS, Kirkland, Canada 6AbbVie, St. Laurent, Canada

P700: Epidemiology of genital lymphoedema as the initial presentation of paediatric Crohn's diseaseECCO '17 Barcelona
Year: 2017
Authors:

Jagger F.*1, Dall A.2, Henderson P.2, Wilson D.1

1University of Edinburgh, Child Life and Health, Edinburgh, United Kingdom 2Royal Hospital For Sick Children, Department of Pediatric Gastroenterology, Edinburgh, United Kingdom

P701: Late-onset Crohn's disease is associated with high risk of intestinal perforation and low risk of perianal fistula as compared with early-onset Crohn's disease: the CONNECT cohortECCO '17 Barcelona
Year: 2017
Authors:

Kim H.M.*1, Kim H.-S.1, Kim J.S.2, Kim Y.S.3, Cheon J.H.4, Ye B.D.5, Kim Y.H.6, Han D.S.7

1Yonsei University Wonju College of Medicine, Division of Gastroenterology and Hepatology, Wonju, South Korea 2Seoul National Uinversity College of Medicine, Internal Medicine and Liver Research Institute, Seoul, South Korea 3Inje University College of Medicine, Internal Medicine, Seoul, South Korea 4Yonsei University College of Medicine, Internal Medicine and Institute of Gastroenterology, Seoul, South Korea 5University of Ulsan College of Medicine, Asan Medical Center, Gastroenterology and Inflammatory Bowel Disease Center, Seoul, South Korea 6Sungkyunkwan University School of Medicine, Department of Internal Medicine, Seoul, South Korea 7Hanyang University Guri Hospital, Department of Internal Medicine, Guri, South Korea

P702: F-calprotectin use in inflammatory bowel disease is characterized by improved diagnostic accuracy, less patient harm and decreased costs, compared with conventional serological markers and colonoscopy. A cost-effectiveness study in ItalyECCO '17 Barcelona
Year: 2017
Authors:

Mascialino B.*1, Vora A.2

1Thermo Fisher Scientific, ImmunoDiagnostics, Uppsala, Sweden 2Thermo Fisher Scientific, ImmunoDiagnostics, San Francisco, United States

P703: Risk of disease progression in patients with Crohn's disease after 7 years of follow-up in a Danish population-based inception cohortECCO '17 Barcelona
Year: 2017
Authors:

Burisch J.*1, Vind I.2, Prosberg M.2, Dubinsky M.3, Siegel C.A.4, Bendtsen F.2, Vester-Andersen M.2,5

1North Zealand University Hospital, Department of Gastroenterology, Frederikssund, Denmark 2Hvidvore University Hospital, Gastrounit, medical section, Hvidovre, Denmark 3Susan and Leonard Feinstein IBD Clinical Center Icahn School of Medicine at Mount Sinai, Departments of Medicine and Pediatrics, New York, United States 4Dartmouth-Hitchcock Medical Center, Section of Gastroenterology and Hepatology, New Hampshire, United States 5Zealand University Hospital, Department of Medical Gastroenterology, Køge, Denmark

P704: The impact of travel distance on disease outcomes in inflammatory bowel diseaseECCO '17 Barcelona
Year: 2017
Authors:

Borren N.*1,2, Tan W.1, Andrews E.1, Khalili H.1,3, Garber J.1,3, Yajnik V.1,3, Ananthakrishnan A.1,3

1Massachusetts General Hospital, Department of Gastroenterology, Boston, United States 2University of Groningen, Groningen, Netherlands 3Harvard Medical School, Boston, United States

P705: Peripheral arterial disease is associated with an increased risk of elderly-onset inflammatory bowel diseaseECCO '17 Barcelona
Year: 2017
Authors:

Peerani F.*1, Chang H.2, Ungaro R.3, Torres J.3, Atreja A.3, Colombel J.-F.3

1University of Alberta, Dept. of Medicine and Division of Gastroenterology, Edmonton, Canada 2Icahn School of Medicine at Mount Sinai, Dept. of Population Health Science and Policy, New York, United States 3Icahn School of Medicine at Mount Sinai, Dr. Henry D. Janowitz Division of Gastroenterology, New York, United States